Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.

Antonio Ruggiero, Piero Valentini, Roberta Onesimo, Daniela Rizzo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

3 Citazioni (Scopus)

Abstract

Anti-E alloimmunisation is a less common cause of haemolytic disease in the newborn (HDN) and is usually associated with mild to moderate clinical manifestations, that are often less severe than anti-D immunisation. Conventional treatments for HDN are phototherapy and exchange transfusion, the latter still representing a high-risk procedure. Currently, intravenous immunoglobulin has been used as alternative treatment for HDN to reduce the need for exchange transfusion, as well as the length of phototherapy and hospitalisation. We report a case of anti-E HDN treated successfully with intravenous immunoglobulin, as adjuvant treatment to phototherapy.
Lingua originaleEnglish
pagine (da-a)1059-1061
Numero di pagine3
RivistaTHE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Volume23
Stato di pubblicazionePubblicato - 2010

Keywords

  • anti-E hemolytic disease in the newborn.

Fingerprint Entra nei temi di ricerca di 'Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.'. Insieme formano una fingerprint unica.

Cita questo